ArticleScientific reports2026

miR-30b-5p suppresses prostate cancer progression by targeting FLVCR1 through the cAMP/PKA/CREB pathway.

Dong Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.